Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leo Zhang

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Oncotarget|July 25, 2016
Gene mutations and actionable genetic lesions in mantle cell lymphomaMakhdum Ahmed, Leo Zhang, Krystle Nomie, et al.
The Proceedings of the Nutrition Society|June 24, 2021
Inflammatory bowel disease and the gut microbiotaNan Wu, Cassandra Mah, Sabrina Koentgen, et al.
Aperture Neuro|September 1, 2023
Rodent Whole-Brain fMRI Data Preprocessing ToolboxNan Xu, Leo Zhang, Sam Larson, et al.
Blood Cancer Journal|March 22, 2018
The CD20-specific engineered toxin antibody MT-3724 exhibits lethal effects against mantle cell lymphomaShengjian Huang, Changying Jiang, Hui Zhang, et al.
Small (Weinheim an Der Bergstrasse, Germany)|February 4, 2025
Effect of Brief Electrical Stimulation on Cell Biomechanics in Hereditary Sensory NeuropathyDaniel Ta, Anu Anthony, Ashour Sliow, et al.
Blood Advances|August 18, 2018
Activation of MYC, a bona fide client of HSP90, contributes to intrinsic ibrutinib resistance in mantle cell lymphomaJimmy Lee, Liang Leo Zhang, Wenjun Wu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 19, 2018
Strategic Therapeutic Targeting to Overcome Venetoclax Resistance in Aggressive B-cell LymphomasLan V Pham, Shengjian Huang, Hui Zhang, et al.
Blood Advances|February 11, 2021
Inhibition of B-cell receptor signaling disrupts cell adhesion in mantle cell lymphoma via RAC2Wenjun Wu, Weige Wang, Carrie A Franzen, et al.
The Lancet. Oncology|December 8, 2015
Ibrutinib in combination with rituximab in relapsed or refractory mantle cell lymphoma: a single-centre, open-label, phase 2 trialMichael L Wang, Hun Lee, Hubert Chuang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 29, 2017
B-Cell Lymphoma Patient-Derived Xenograft Models Enable Drug Discovery and Are a Platform for Personalized TherapyLeo Zhang, Krystle Nomie, Hui Zhang, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Oncotarget|July 25, 2016
Gene mutations and actionable genetic lesions in mantle cell lymphomaMakhdum Ahmed, Leo Zhang, Krystle Nomie, et al.
The Proceedings of the Nutrition Society|June 24, 2021
Inflammatory bowel disease and the gut microbiotaNan Wu, Cassandra Mah, Sabrina Koentgen, et al.
Aperture Neuro|September 1, 2023
Rodent Whole-Brain fMRI Data Preprocessing ToolboxNan Xu, Leo Zhang, Sam Larson, et al.
Blood Cancer Journal|March 22, 2018
The CD20-specific engineered toxin antibody MT-3724 exhibits lethal effects against mantle cell lymphomaShengjian Huang, Changying Jiang, Hui Zhang, et al.
Small (Weinheim an Der Bergstrasse, Germany)|February 4, 2025
Effect of Brief Electrical Stimulation on Cell Biomechanics in Hereditary Sensory NeuropathyDaniel Ta, Anu Anthony, Ashour Sliow, et al.
Blood Advances|August 18, 2018
Activation of MYC, a bona fide client of HSP90, contributes to intrinsic ibrutinib resistance in mantle cell lymphomaJimmy Lee, Liang Leo Zhang, Wenjun Wu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 19, 2018
Strategic Therapeutic Targeting to Overcome Venetoclax Resistance in Aggressive B-cell LymphomasLan V Pham, Shengjian Huang, Hui Zhang, et al.
Blood Advances|February 11, 2021
Inhibition of B-cell receptor signaling disrupts cell adhesion in mantle cell lymphoma via RAC2Wenjun Wu, Weige Wang, Carrie A Franzen, et al.
The Lancet. Oncology|December 8, 2015
Ibrutinib in combination with rituximab in relapsed or refractory mantle cell lymphoma: a single-centre, open-label, phase 2 trialMichael L Wang, Hun Lee, Hubert Chuang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 29, 2017
B-Cell Lymphoma Patient-Derived Xenograft Models Enable Drug Discovery and Are a Platform for Personalized TherapyLeo Zhang, Krystle Nomie, Hui Zhang, et al.
Pageof 1